News About: Pharm. Industry
Hanmi to launch Japanese encephalitis live vaccineHami Pharm says it will launch its imported Japanese encephalitis live vaccine 'CD-Zevax inj' in the middle of next April for the first time in Korea, through a co-marketing wit...
|
Venture technology evaluation and certification system to be further strengthened
The technology evaluation and certification system for verifying the technology level of bioventure firms objectively will be further promoted, according to the Korea Bioventure Association at its second general meeti...
Pelle, soccer hero, on advertising model for impotence campaign.Pfizer contracted a business partnership with Mr. Pelle, the world soccer hero, for marketing promotional campaign in order to alleviate consumer's negative feelings over the im...
|
26 drug companies to form Korea Bio Pharmaceutical Center
26 drug companies intended to take part in the foundation of Korea Biopharmaceutical Center (Temporary name) in Scotland according to the survey conducted by Korea Health Industrial Promotion Board against 77 domestic...
Civil organizations attack the government's insurance policy including Gleevec
Two civil organizations both for chronic leukemia patients and for promotion of public drugs including Gleevec have recently petitioned the Human Rights Committee, to this effect that the current insurance system, whi...
Dong-A Pharm to file a new drug application for DA-9601
Dong-A Pharm, a drug manufacturer of Gaster (famotidine), has filed a new drug application for its gastric mucosa protective DA-9601 to the Korea Food and Drug Administration on March 15th, after completing its Phase ...
KBRI showing excellent performances in 3 year assessment
Korea Bio-engineering Research Institute (KBRI) established as an independent corporation in May 1999 has been praised as an excellent research performer over years with remarkable progress.
A researcher of the KBR...
Chosun Pharm determined to shorten the management normalization
A total of 230 employees in Chosun Pharm are struggling to normalize the company management through their in-house campaign to further enhance the productivity and ensure the containment of costs (e.g., double role, m...
Persistent counterfeit Viagra and Xenical rampant
Business industry sources says that the unfair or illegal distribution of some renowned items, such as Vigra and Xenical, has been persistently rampant as a result of the recent KFDA inspection of medical institutions...
Korean pharmaceutical industry has potentiality in biotec.
Mr. Robert A. Ingram, the CEO of Glaxo Smith Kline, who visited to Korea on March 11 took a press interview on 13, advising that the R&D of bio technology in the pharmaceutical industry should be closely bound with th...
